Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Voyager Therapeutics Raises $60 Million in Oversubscribed Series B Financing Read more →
- MolMed expands its pipeline by entering the CAR-T field having exercised the option right on San Raffaele Hospital CAR-CD44v6 project Read more →
- Cytori Provides Twelve Month Data Update on Scleradec-I Trial Read more →